Hutch News

Hutch News

Stories tagged 'head neck cancers'

HPV vaccine boosts immune memory

A single dose of the HPV vaccine can strengthen immune memory in people who’ve previously been infected with HPV — and potentially help prevent re-infection

Aug. 10, 2016 | By Sabrina Richards / Fred Hutch News Service

It’s long been known that the vaccine against the human papilloma virus offers protection when administered to those who’d never experienced HPV infection. But new research suggests the possibility that it could also help those who’d been previously infected to guard against re-infection, according to results recently published in EBioMedicine.

View story >


Forgotten patients: New guidelines help those with head-and-neck cancers

Stigma, isolation and medical complexity may keep patients from getting all the care they need; recommendations aim to change that

April 8, 2016 | By Diane Mapes and Sabrina Richards / Fred Hutch News Service

Head-and-neck cancer survivors can have enormous aftereffects from the disease and its treatment. New survivorship guidelines just released by the American Cancer Society should help them get the support they need.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

March 3, 2016

Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care; Hutch study finds CMV viral load can act as surrogate endpoint for clinical trials; A new target for Tumor Paint: BLZ-100 lights up head and neck cancers; Dr. Stephen Tapscott appointed to NIAMS advisory council

View story >


Patients treated at cancer centers live longer: study

Finding of survival-rate differences between cancer hubs and community hospitals spurs call to ‘figure out the gaps’

Nov. 6, 2015 | By Bill Briggs / Fred Hutch News Service

Patients treated at one of 11 specialized cancer centers had higher survival rates compared to cancer patients treated at community hospitals, a study found.

View story >


New hope for patients with hard-to-treat head and neck cancers

Treatment could shrink tumors before surgery and reduce chemotherapy’s damaging side effects; clinical trial to launch later this year

Aug. 13, 2014 | By Dr. Rachel Tompa / Fred Hutch News Service

Using a technique that looks for genes that tumor cells need to survive, Fred Hutchinson Cancer Research Center scientists have identified a potential new drug for a class of difficult-to-treat head and neck cancers.

View story >


Surviving head, neck cancers: 'where you're treated matters'

Dr. Eduardo Méndez, colleagues at Fred Hutchinson Cancer Research Center find high-volume hospitals, dedicated cancer centers produce higher survival rates in older head and neck cancer patients

March 4, 2013 | By Dean Forbes

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.